Die letzten Pressemitteilungen zu dem Thema apricus biosciences

PresseMitteilungen zu dem Schlagwort apricus biosciences

DGAP-News: Apricus Biosciences vor Ubernahme des umsatzstarksten Vertriebs- und Marketingunternehmens fur Medikamente in Frankreich

21.06.2012: Apricus Biosciences, Inc. 21.06.2012 22:44 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Appointment of Paul V. Maier to Its Board of Directors

04.06.2012: Apricus Biosciences, Inc. 04.06.2012 15:39 ------------------------- ...

DGAP-News: Apricus Biosciences Strengthens Vitaros(R) and Nexact(R) Patent Estate With Two New Patent Allowances

25.05.2012: Apricus Biosciences, Inc. 25.05.2012 19:20 ------------------------- ...

DGAP-News: Apricus Biosciences Granted Regulatory Guidance With FDA for MycoVa(TM) for the Treatment of Onychomycosis

22.05.2012: Apricus Biosciences, Inc. 22.05.2012 16:13 ------------------------- ...

DGAP-News: Apricus Biosciences Granted Regulatory Meeting With FDA for Femprox(R) for the Treatment of Female Sexual Arousal Disorder

21.05.2012: Apricus Biosciences, Inc. 21.05.2012 15:35 ------------------------- ...

DGAP-News: Apricus Biosciences to Present at the 11th Annual JMP Securities Research Conference

14.05.2012: Apricus Biosciences, Inc. 14.05.2012 15:42 ------------------------- ...

DGAP-News: Health Canada Grants Apricus Biosciences Pre-NDS Meeting for MycoVa(TM) for the Treatment of Onychomycosis

11.05.2012: Apricus Biosciences, Inc. 11.05.2012 15:55 ------------------------- ...

DGAP-News: Apricus Biosciences Announces First Quarter 2012 Financial Results Conference Call and Provides Corporate Update

08.05.2012: Apricus Biosciences, Inc. 08.05.2012 15:49 ------------------------- ...

DGAP-News: Health Canada Grants Apricus Biosciences Pre-NDS Meeting for Femprox for Female Sexual Arousal Disorder

07.05.2012: Apricus Biosciences, Inc. 07.05.2012 16:10 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Poster Presentation of Femprox(R) Phase III Clinical Data at American Urological Association Annual Meeting

04.05.2012: Apricus Biosciences, Inc. 04.05.2012 16:05 ------------------------- ...

DGAP-News: Apricus Biosciences Receives Notice of Issuance for First Prevonco(TM) Patent in the United States

26.04.2012: Apricus Biosciences, Inc. 26.04.2012 18:00 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Allowance of a NexACT(R) Technology-Based Patent in Europe for the Manufacture of DDAIP

22.03.2012: Apricus Biosciences, Inc. 22.03.2012 12:00 ------------------------- ...

DGAP-News: Apricus Biosciences, San Diego Hospice and The Institute for Palliative Medicine Announce a Broad Clinical Research Program Using NexACT(R) Technology

14.03.2012: Apricus Biosciences, Inc. 14.03.2012 15:05 ------------------------- ...

DGAP-News: Elis Pharma Introduces Erectile Dysfunction Drug, Vitaros(R) Licensed From Apricus Biosciences at Major Pharmaceutical Conference in Dubai

09.03.2012: Elis Pharmaceuticals Limited 09.03.2012 18:50 ---------------------- ...

DGAP-News: Apricus Biosciences CEO is Interviewed on CDTV.Net

06.03.2012: Apricus Biosciences, Inc. 06.03.2012 16:01 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Shareholder Update With New Focus as a Commercially-Driven Specialty Pharmaceutical Company

16.02.2012: Apricus Biosciences, Inc. 16.02.2012 16:06 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Acquisition of NitroMist(TM) Rights Outside North America

03.02.2012: Apricus Biosciences, Inc. 03.02.2012 15:41 ------------------------- ...

DGAP-News: Apricus Biosciences Expands Commercial Oncology Offerings Through Agreement With Pediatrx for U.S. Co-Promotion of GRANISOL(R) (Granisetron) Oral Solution and AQUORAL(TM) Spray and Purchase of Non-U.S. Rights to GRANISOL(R)

27.01.2012: Apricus Biosciences, Inc. 27.01.2012 14:00 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Allowance of Israeli Patent, Expanding Its Patent Portfolio for the Topical Treatment of Premature Ejaculation

17.01.2012: Apricus Biosciences, Inc. 17.01.2012 16:03 ------------------------- ...

DGAP-News: Apricus Biosciences and Elis Pharma Sign License Agreement for MycoVa(TM) in the Middle East and the Gulf

10.01.2012: Apricus Biosciences, Inc. 10.01.2012 15:51 ------------------------- ...

DGAP-News: Apricus Biosciences to Webcast Today's Presentation at Biotech Showcase(TM) 2012 in San Francisco

09.01.2012: Apricus Biosciences, Inc. 09.01.2012 22:22 ------------------------- ...

DGAP-News: Apricus Biosciences and Abbott Sign Exclusive Agreement to Market Vitaros(R) (Alprostadil) in Canada

09.01.2012: Apricus Biosciences, Inc. 09.01.2012 18:29 ------------------------- ...

DGAP-News: Apricus Biosciences CEO, Dr. Bassam Damaj, to Present at Biotech Showcase(TM) 2012 in San Francisco

04.01.2012: Apricus Biosciences, Inc. 04.01.2012 15:49 ------------------------- ...

DGAP-News: Apricus Biosciences and Stellar Pharmaceuticals Announce Exclusive License Agreement in Canada for the Commercialization of MycoVa(TM) for Onychomycosis

03.01.2012: Apricus Biosciences, Inc. 03.01.2012 15:00 ------------------------- ...

DGAP-News: Apricus Biosciences Completes Acquisition of Topotarget USA, Inc.

29.12.2011: Apricus Biosciences, Inc. 29.12.2011 18:30 ------------------------- ...

DGAP-News: Apricus Biosciences Launches Commercialization Arm With Definitive Agreement to Acquire Topotarget USA

16.12.2011: Apricus Biosciences, Inc. 16.12.2011 14:00 ------------------------- ...

DGAP-News: Apricus Biosciences Press Release

15.12.2011: Apricus Biosciences, Inc. 15.12.2011 16:18 ------------------------- ...

DGAP-News: Apricus Biosciences, Inc. Press Release

12.12.2011: Apricus Biosciences, Inc. 12.12.2011 18:16 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Allowance of Additional NexACT(R) Patent in Japan

08.12.2011: Apricus Biosciences, Inc. 08.12.2011 16:01 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Appointment of Dr. Kleanthis G. Xanthopoulos to Its Board of Directors

21.11.2011: Apricus Biosciences, Inc. 21.11.2011 15:51 ------------------------- ...

DGAP-News: Apricus Biosciences Announces That Its NexACT(R) Partner Exodos Life Sciences Has Completed Its pre-IND Meeting With the FDA

15.11.2011: Apricus Biosciences, Inc. 15.11.2011 15:30 ------------------------- ...

DGAP-News: Femprox(R) Phase III Clinical Data From Apricus Biosciences Chosen for a Presentation at the European Society for Sexual Medicine

14.11.2011: Apricus Biosciences, Inc. 14.11.2011 15:47 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Third Quarter 2011 Financial Results Conference Call

11.11.2011: Apricus Biosciences, Inc. 11.11.2011 19:16 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Issuance of Korean Patent, Expanding Its Patent Portfolio for Its Topical Cream to Treat Premature Ejaculation

19.10.2011: Apricus Biosciences, Inc. 19.10.2011 15:30 ------------------------- ...

DGAP-News: Apricus Biosciences Announces New Data Published in the International Journal of Pharmaceutics Confirming Efficiency of NexACT(R) Drug Delivery Technology

13.10.2011: Apricus Biosciences, Inc. 13.10.2011 17:30 ------------------------- ...

DGAP-News: Apricus Biosciences to Present Poster of Femprox(R) Phase III Clinical Data at Upcoming Industry Conference

06.10.2011: Apricus Biosciences, Inc. 06.10.2011 15:52 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Korean Patent Approval for MycoVa(TM) for Nail Fungus

03.10.2011: Apricus Biosciences, Inc. 03.10.2011 17:03 ------------------------- ...

DGAP-News: Apricus Biosciences to Provide Overview of Rx and Consumer Healthcare Divisions at the 11th Annual Biotech in Europe Investor Forum

09.09.2011: Apricus Biosciences, Inc. 09.09.2011 20:51 ------------------------- ...

DGAP-News: Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

31.08.2011: Apricus Biosciences, Inc. 31.08.2011 15:47 ------------------------- ...

DGAP-News: Photo Release -- Apricus Biosciences Announces FDA Clearance for Its First Anti-Fungal OTC Drug (Tolnaftate-D(TM)) Containing NexACT(R) Technology

18.08.2011: Apricus Biosciences, Inc. 18.08.2011 15:00 ------------------------- ...

DGAP-News: Apricus Biosciences Announces Second Quarter 2011 Financial Results Conference Call

11.08.2011: Apricus Biosciences, Inc. 11.08.2011 22:30 ------------------------- ...

Die letzten Pressemitteilungen zu dem Thema apricus biosciences

Neu hier ?

Werbung

Food-News

Facebook

Community

Sponsoren

Firmenverzeichniss